UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Medline ® Abstract for Reference 100

of 'Noninvasive assessment of hepatic fibrosis: Ultrasound-based elastography'

100
TI
Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference.
AU
Kircheis G, Sagir A, Vogt C, Vom Dahl S, Kubitz R, Häussinger D
SO
World J Gastroenterol. 2012 Mar;18(10):1077-84.
 
AIM: To evaluate cut-off values and performance of acoustic radiation force impulse imaging (ARFI) using transient elastography [FibroScan©(FS)]as a reference.
METHODS: Six hundred and six patients were enrolled in this study. All patients underwent liver stiffness measurement with FS (FS-LS) and ARFI (with shear wave velocity quantification; ARFI-SWV) and the performance of ARFI in comparison to FS was determined. Sixty-eight patients underwent liver biopsy.
RESULTS: Significantly higher success rates for the determination of liver stiffness were found using ARFI as compared to FS [604/606 (99.7%) vs. 482/606 (79.5%), P<0.001]. ARFI-SWV correlated significantly with FS-LS (r = 0.920, P<0.001). ARFI-SWV increased significantly with the stage of fibrosis (1.09±0.13 m/s for patients with no significant fibrosis (FS-LS<7.6 kPa); 1.46±0.27 m/s for patients with significant liver fibrosis (7.6<FS-LS≤13.0 kPa); and 2.55±0.77 m/s for patientswith liver cirrhosis (FS-LS>13.0 kPa)). ARFI-SWV cut-off values were identified for no significant fibrosis (1.29 m/s; sensitivity 91.4% and specificity 92.6%) and for liver cirrhosis (1.60 m/s; sensitivity 92.3% and specificity 96.5%). The optimal cut-off value for predicting liver fibrosis (F≥2) was 1.32 m/s (sensitivity 87.0% and specificity 80.0%) and for liver cirrhosis (F4) 1.62 m/s (sensitivity 100% and specificity 85.7%), for patients who underwent liver biopsy. An excellent inter-and intraobserver reproducibility was observed for ARFI-SWV determinations.
CONCLUSION: An ARFI-SWV cut-off value of 1.29 m/s seems to be optimal for patients with no significant liver fibrosis and 1.60 m/s for patients with liver cirrhosis.
AD
Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Moorenstrasse 5, Düsseldorf 40225, Germany.
PMID